In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer.
Kemeny
Nancy
N
Memorial Sloan-Kettering Cancer Center (MSKCC), USA.
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D003907:Dexamethasone / Q000008:administration & dosage; D005467:Floxuridine / Q000008:administration & dosage*; D005472:Fluorouracil / Q000008:administration & dosage; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D016019:Survival Analysis; D014481:United States
D000964:Antimetabolites, Antineoplastic; D005467:Floxuridine; D003907:Dexamethasone; D002955:Leucovorin; D005472:Fluorouracil